BACKGROUND: Cervical cancer incidence has decreased over time in England particularly after the introduction of organized screening. In Portugal, where opportunistic screening has been widely available with only slightly lower coverage than that of the organized programme in England, rates of cervical cancer have been higher than in England. We compared the burden of cervical cancer, risk factors and preventive interventions over time in both countries, to identify elements hindering the further decline in incidence and mortality in Portugal. METHODS: We used joinpoint regression to identify significant changes in rate time-trends. We also analyzed individual-level Portuguese data on sexual behaviour and human papillomavirus prevalence, and...
Abstract Human papillomavirus (HPV) is the most common sexually transmitted disease in the world. Th...
textabstractWorldwide, cervical cancer is the second most common female malignancy, diagnosed in 500...
BACKGROUND: In four randomised trials, human papillomavirus (HPV)-based screening for cervical cance...
Cervical cancer incidence has decreased over time in England particularly after the introduction of ...
Despite having a similar healthcare system, Portugal has almost 50% higher cervical cancer incidence...
To describe variation in incidence and mortality rates of cervical cancer (CC), between 4 Southern E...
BACKGROUND: The incidence of cervical cancer varies dramatically, both globally and within individua...
A questionnaire survey was conducted by the Epidemiology Working Group of the European Cervical Canc...
Background Worldwide, cervical cancer is the 4th most common cancer in women. The highest incidence...
PURPOSE: With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burde...
Context: This article compares cervical cancer screening intensity and cervical cancer mortality tre...
Background: The aim was to analyse participation trajectories in organised breast and cervical cance...
Purpose: With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burde...
<p>The European Council recommends that organised cervical cancer screening be offered in all ...
Context: This article compares cervical cancer screening intensity and cervical cancer mortality tre...
Abstract Human papillomavirus (HPV) is the most common sexually transmitted disease in the world. Th...
textabstractWorldwide, cervical cancer is the second most common female malignancy, diagnosed in 500...
BACKGROUND: In four randomised trials, human papillomavirus (HPV)-based screening for cervical cance...
Cervical cancer incidence has decreased over time in England particularly after the introduction of ...
Despite having a similar healthcare system, Portugal has almost 50% higher cervical cancer incidence...
To describe variation in incidence and mortality rates of cervical cancer (CC), between 4 Southern E...
BACKGROUND: The incidence of cervical cancer varies dramatically, both globally and within individua...
A questionnaire survey was conducted by the Epidemiology Working Group of the European Cervical Canc...
Background Worldwide, cervical cancer is the 4th most common cancer in women. The highest incidence...
PURPOSE: With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burde...
Context: This article compares cervical cancer screening intensity and cervical cancer mortality tre...
Background: The aim was to analyse participation trajectories in organised breast and cervical cance...
Purpose: With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burde...
<p>The European Council recommends that organised cervical cancer screening be offered in all ...
Context: This article compares cervical cancer screening intensity and cervical cancer mortality tre...
Abstract Human papillomavirus (HPV) is the most common sexually transmitted disease in the world. Th...
textabstractWorldwide, cervical cancer is the second most common female malignancy, diagnosed in 500...
BACKGROUND: In four randomised trials, human papillomavirus (HPV)-based screening for cervical cance...